2020 - Fellow, National Academy of Inventors
2018 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of study are Nanotechnology, Nanoparticle, Drug delivery, Nanomedicine and Membrane. His work on Coating as part of his general Nanotechnology study is frequently connected to Extramural, thereby bridging the divide between different branches of science. His Nanoparticle research integrates issues from Combinatorial chemistry, Biophysics, Liposome and Particle size.
Liangfang Zhang has researched Drug delivery in several fields, including Ethylene glycol, Cancer research and Cell culture. His work deals with themes such as Human disease and Emerging technologies, which intersect with Nanomedicine. His biological study spans a wide range of topics, including Surface modification and Adsorption.
His main research concerns Nanotechnology, Nanoparticle, Drug delivery, Membrane and Nanomedicine. His Nanotechnology study combines topics from a wide range of disciplines, such as Cancer cell, Biological fluids and Surface modification. His Nanoparticle research is multidisciplinary, relying on both Liposome, Biophysics, Polymer, Combinatorial chemistry and Dispersity.
His Biophysics study integrates concerns from other disciplines, such as Biochemistry and Intracellular. In his study, Cancer is inextricably linked to Drug, which falls within the broad field of Drug delivery. His Membrane research includes themes of Platelet and Red blood cell.
Liangfang Zhang mainly investigates Nanotechnology, Biophysics, Cell biology, Nanomedicine and Membrane. His work in the fields of Nanotechnology, such as Nanoparticle and Nanorobotics, overlaps with other areas such as Micromotor. The various areas that Liangfang Zhang examines in his Biophysics study include Platelet, Extracellular vesicles, Intracellular and Drug.
His research in Cell biology intersects with topics in Epitope, Antimicrobial and Immune system. His Nanomedicine study incorporates themes from Immune modulation and Targeted drug delivery, Drug delivery. His work in Membrane tackles topics such as Cell which are related to areas like Small molecule and In vivo.
His primary areas of study are Nanotechnology, Nanomedicine, In vivo, Membrane and Micromotor. His work deals with themes such as Cancer cell, Cancer treatment and Staphylococcus aureus bacteria, which intersect with Nanotechnology. His Nanomedicine research incorporates themes from Coating, Engineering ethics and Rational design.
The various areas that he examines in his In vivo study include Niche, Regenerative medicine, Biocompatibility, Oxygen delivery and Cell biology. Biological membrane and Cell membrane are among the areas of Membrane where Liangfang Zhang concentrates his study. Liangfang Zhang combines subjects such as Cancer research, Glioma, Drug and Peptide with his study of Drug delivery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nanoparticles in Medicine: Therapeutic Applications and Developments
L Zhang;FX Gu;JM Chan;AZ Wang.
Clinical Pharmacology & Therapeutics (2008)
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Che Ming J. Hu;Li Zhang;Santosh Aryal;Connie Cheung.
Proceedings of the National Academy of Sciences of the United States of America (2011)
Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer
Vaishali Bagalkot;Liangfang Zhang;Etgar Levy-Nissenbaum;Sangyong Jon.
Nano Letters (2007)
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
Liangfang Zhang;Juliana M. Chan;Frank X. Gu;June Wha Rhee.
ACS Nano (2008)
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.
Frank Gu;Liangfang Zhang;Benjamin A. Teply;Nina Mann.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang L;Pornpattananangku D;Hu Cm;Huang Cm.
Current Medicinal Chemistry (2010)
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Juliana M. Chan;Liangfang Zhang;Kai P. Yuet;Grace Liao.
Nanoparticle biointerfacing by platelet membrane cloaking
Che Ming J. Hu;Ronnie H. Fang;Kuei Chun Wang;Brian T. Luk.
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang;Che-Ming J. Hu;Brian T. Luk;Weiwei Gao.
Nano Letters (2014)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu;Liangfang Zhang.
Biochemical Pharmacology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: